Skip to content
by Legal Desire
Lawyer profile

Jason Caron

Latham & Watkins LLP
Claim this profile
Firm
Latham & Watkins LLP
Practice
healthcare, Healthcare & Life Sciences, healthcare and life sciences
Office
Washington, D.C.
Active in the record
2023 to 2026

Deal experience

Recent deals

12 announced deals in the record
Latham Advises Medical Faculty Associates in Transaction With the George Washington University and Universal Health Services 11 Aug 2026
Restructuring & Insolvency Healthcare & Life Sciences Latham & Watkins LLP Lead Healthcare & Life Sciences Washington, D.C.
Latham & Watkins Advises CordenPharma on Acquisition of AmbioPharm 4 Aug 2026
M&A Healthcare & Life Sciences Latham & Watkins LLP life sciences and regulatory Washington, D.C.
Latham & Watkins Advises Goldman Sachs Alternatives on Investment in LearnWell 10 Feb 2026
Venture Capital & Growth Healthcare & Life Sciences Latham & Watkins LLP healthcare regulatory Washington, D.C.
Latham & Watkins Advises on Fulgent Genetics’ Acquisition of Bako Diagnostics and StrataDX 23 Dec 2025
M&A Healthcare & Life Sciences Latham & Watkins LLP USD 55.5m healthcare Washington, D.C.
Latham & Watkins Advises on Medline’s Upsized Landmark US$7.2 Billion IPO 19 Dec 2025
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 7.20bn healthcare regulatory
Latham & Watkins Advises Clario in US$8.875 Billion Sale to Thermo Fisher Scientific 4 Nov 2025
M&A Healthcare & Life Sciences Latham & Watkins LLP USD 8.88bn healthcare regulatory Washington, D.C.
Latham & Watkins Advises NEA on Acquisition and Take Private of NeueHealth With Consortium of Investors 26 Dec 2024
M&A Healthcare & Life Sciences Latham & Watkins LLP USD 1.30bn healthcare regulatory Washington, D.C.
Latham & Watkins Advises on Concentra IPO 26 Jul 2024
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 23.5 healthcare regulatory matters Washington, D.C.
Latham & Watkins Advises Goldman Sachs in Acquisition of Xpress Wellness 24 May 2024
M&A Healthcare & Life Sciences Latham & Watkins LLP healthcare regulatory Washington, D.C.
Latham & Watkins Advises Goldman Sachs Asset Management in US$150 Million Series B Funding for Rapport Therapeutics 2 Nov 2023
Venture Capital & Growth Healthcare & Life Sciences Latham & Watkins LLP USD 150m healthcare Washington, D.C.
Pro

See all 12 deals for Jason Caron

This page shows the 10 most recent. The paid plans open the complete history for this lawyer, with full filtering, plus:

  • Complete deal history, filtered by keyword, deal type, sector and year
  • Deals by year, sector and deal type
  • Frequent co-counsel and the firms most often on the other side
  • Repeat clients, as named in the announcements
  • CSV and Excel export
Is this you?

Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.

Claim this profile

Suggest a correction